Surgical strategies in the treatment of MR-negative Cushing's Disease: a systematic review and treatment algorithm

Andrew B Yang1, Fraser Henderson2, Theodore H Schwartz3

  • 1Weill Cornell Medical School, New York, NY, USA.

Pituitary
|June 17, 2022
PubMed
Abstract

Insights

Surgery for MRI-negative Cushing's Disease offers good remission rates. Best outcomes occur when a tumor is found; otherwise, gland resection guided by inferior petrosal sinus sampling (IPSS) is recommended.

Area of Science:

  • Neurosurgery
  • Endocrinology
  • Oncology

Background:

  • Cushing's Disease (CD) is a rare endocrine disorder caused by excess cortisol.
  • Magnetic resonance imaging (MRI) negative CD presents a diagnostic and therapeutic challenge.
  • Surgical management of MRI-negative CD involves pituitary gland resection, often guided by inferior petrosal sinus sampling (IPSS).

Purpose of the Study:

  • To systematically review and compare surgical strategies for MRI-negative Cushing's Disease.
  • To evaluate remission and hypopituitarism rates associated with different surgical approaches.

Main Methods:

  • Systematic literature review of studies on surgical outcomes in MRI-negative CD.
  • Inclusion criteria: clearly described surgical strategy, reported remission and/or hypopituitarism rates.
  • Categorization of surgical strategies into 6 distinct resection approaches.

Main Results:

  • 12 studies reported remission rates; 5 studies reported hypopituitarism rates.
  • Tumor resection yielded 68% remission (0% hypopituitarism).
  • If tumor unidentified, resection strategies showed variable outcomes: 78% remission (no data) for inferior 1/3 resection, 68% remission (13% hypopituitarism) for 30-50% gland resection guided by IPSS, and 66% remission (67% hypopituitarism) for total gland resection.

Conclusions:

  • Surgery is a viable treatment for MRI-negative Cushing's Disease.
  • Optimal outcomes are achieved when a tumor is identified and resected.
  • If no tumor is found, gland resection guided by IPSS or preserving central gland function is suggested, though data limitations exist.